Product NDC: | 0469-0871 |
Proprietary Name: | Adenoscan |
Non Proprietary Name: | adenosine |
Active Ingredient(s): | 3 mg/mL & nbsp; adenosine |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0469-0871 |
Labeler Name: | Astellas Pharma US, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA020059 |
Marketing Category: | NDA |
Start Marketing Date: | 19950518 |
Package NDC: | 0469-0871-30 |
Package Description: | 10 VIAL in 1 CARTON (0469-0871-30) > 30 mL in 1 VIAL |
NDC Code | 0469-0871-30 |
Proprietary Name | Adenoscan |
Package Description | 10 VIAL in 1 CARTON (0469-0871-30) > 30 mL in 1 VIAL |
Product NDC | 0469-0871 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | adenosine |
Dosage Form Name | SOLUTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 19950518 |
Marketing Category Name | NDA |
Labeler Name | Astellas Pharma US, Inc. |
Substance Name | ADENOSINE |
Strength Number | 3 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Adenosine Receptor Agonist [EPC],Adenosine Receptor Agonists [MoA] |